ArQule Message Board - Msg: 1442454

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule

ARQL 20.00

0.0%

Jan 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (56)	5/20/1997 9:04:00 PM
From: Czechsinthemail	of 399

Rick, I read your MSN article (which is worthwhile reading for anyone interested in ArQule or other small biotech companies) : investor.msn.com You mentioned both ArQule and Pharmacopia, which are both active in combinatorial chemistry. I like the idea of using this approach to leverage research dollars and was wondering if you could offer a comparison of these companies and Trega Biosciences (the company formerly known as Houghton)--a much smaller cap company that is also active in a combinatorial chem approach. Specifically, do you know how extensive their libraries are, how strong their science is, how their approaches differ, and/or how their prospects look? Any info you have on them would be appreciated. Thanks, Baird

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next